Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
---|---|---|---|---|---|
ILA-H82F5 | Human | Biotinylated Human IL-5 R alpha / CD125 Protein, Avitag™,Fc Tag (MALS verified) |
|
||
ILA-H5269 | Human | Human IL-5 R alpha / CD125 Protein, Fc Tag (MALS verified) |
|
||
ILA-H52H4 | Human | Human IL-5 R alpha / CD125 Protein, His Tag (MALS verified) |
|
Loaded Biotinylated Human IL-5, His,Avitag (Cat. No. IL5-H82Q5) on SA Biosensor, can bind Human IL-5 R alpha, His Tag (Cat. No. ILA-H52H4) with an affinity constant of 12.6 nM as determined in BLI assay (ForteBio Octet Red96e) (QC tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Benralizumab | BIW-8405; KHK-4563; MEDI-563; BIW-8405-IL-5R | Approved | Biowa Inc, Medimmune Llc | Fasenra | United States | Asthma | Astrazeneca Ab | 2017-11-14 | Genetic Diseases, Inborn; Gastroenteritis; Skin Diseases, Genetic; Hypersensitivity; Eczema; Dermatitis, Atopic; Hypersensitivity, Immediate; Pulmonary Disease, Chronic Obstructive; Leukocyte Disorders; Sinusitis; Pemphigoid, Bullous; Asthma; Eosinophilic Esophagitis; Bronchiectasis; Eosinophilic gastroenteritis (EG); Skin Diseases, Eczematous; Dermatitis; Skin Diseases; Immune System Diseases; Chronic Urticaria; Respiratory Tract Diseases; Eosinophilia; Nasal Polyps; Asthma, Exercise-Induced; Eosinophilic Granulomatosis With Polyangiitis; Hematologic Diseases; Hypereosinophilic Syndrome | Details |
Benralizumab | BIW-8405; KHK-4563; MEDI-563; BIW-8405-IL-5R | Approved | Biowa Inc, Medimmune Llc | Fasenra | United States | Asthma | Astrazeneca Ab | 2017-11-14 | Genetic Diseases, Inborn; Gastroenteritis; Skin Diseases, Genetic; Hypersensitivity; Eczema; Dermatitis, Atopic; Hypersensitivity, Immediate; Pulmonary Disease, Chronic Obstructive; Leukocyte Disorders; Sinusitis; Pemphigoid, Bullous; Asthma; Eosinophilic Esophagitis; Bronchiectasis; Eosinophilic gastroenteritis (EG); Skin Diseases, Eczematous; Dermatitis; Skin Diseases; Immune System Diseases; Chronic Urticaria; Respiratory Tract Diseases; Eosinophilia; Nasal Polyps; Asthma, Exercise-Induced; Eosinophilic Granulomatosis With Polyangiitis; Hematologic Diseases; Hypereosinophilic Syndrome | Details |
This web search service is supported by Google Inc.